ARTICLE | Clinical News
MVA-BN RSV: Phase II started
October 24, 2016 7:00 AM UTC
Bavarian Nordic began a single-blind, placebo-controlled, U.S. Phase II trial to evaluate 2 dose levels of MVA-BN RSV given once or twice 4 weeks apart in about 400 healthy volunteers ages >=55....